Biology Reference
In-Depth Information
57 Steinberg SE, Garcia JF, Matzke GR, Mladenovic J (1996) Erythropoietin kinetics in rats: gener-
ation and clearance.
Blood
67: 646-649
58 Fu JS, Lertora JJL, Brookins J, Rice JC, Fisher JW (1988) Pharmacokinetics of erythropoietin in
intact and anephric dogs.
J Lab Clin Med
111: 669-676
59 Dinkelaar RB, Engels EY, Hart AA, Schoemaker LP, Bosch E, Chamuleau RA (1981) Metabolic
studies on erythropoietin (EP): II. The role of liver and kidney in the metabolism of EP.
Exp
Hematol
9: 796-803
60 Fukuda MN, Sasaki H, Lopez L, Fukuda M (1989) Survival of recombinant erythropoietin in the
circulation: The role of carbohydrates.
Blood
73: 84-89
61 Sawyer ST, Krantz SB, Goldwasser E (1987) Binding and receptor-mediated endocytosis of ery-
thropoietin in Friend virus-infected erythroid cells.
J Biol Chem
262: 5554-5562
62 Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA
(1998) Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis.
N
Engl J Med
339: 578-583
63 McLennan DN, Porter CJH, Edwards GA, Martin SW, Heatherington AC, Charman SA (2002)
Lymphatic absorption is the primary contributor to the systemic availability of epoetin alpha fol-
lowing subcutaneous administration to sheep. American Association of Pharmaceutical Scientists
National Meeting, Toronto
